Found: 5
Select item for more details and to access through your institution.
Newly Diagnosed Acute Myeloid Leukemia Patients-Derived Bone Marrow Mesenchymal Stem Cells Suppress Daunorubicin Induced HL-60 Cell Apoptosis via Modulating Caspase-3/Survivin.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2019, v. 27, n. 6, p. 1736, doi. 10.19746/j.cnki.issn1009-2137.2019.06.005
- By:
- Publication type:
- Article
Bone Marrow Mesenchymal Stem Cells from Newly Diagnosed Acute Myeloid Leukemia Patients Exhibit Enhanced Osteogenic Diiferentiation Capacity.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2019, v. 27, n. 4, p. 1277, doi. 10.19746/j.cnki.issn1009-2137.2019.04.047
- By:
- Publication type:
- Article
Effects of Bone Marrow Mesenchymal Stem Cells Derived from Patients with Newly Diagnosed Acute Myeloid Leukemia on the Cell Proliferation, Cell Cycle and Immunophenotypes of HL-60 Cells.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2019, v. 27, n. 4, p. 1259, doi. 10.19746/j.cnki.issn1009-2137.2019.04.044
- By:
- Publication type:
- Article
Endothelial Cells from Human Umbilical Vein Inhibit Generation of Monocyte-Derived Dendritic Cells.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2011, v. 19, n. 2, p. 480
- By:
- Publication type:
- Article
Single-center phase 2 study of PD-1 inhibitor combined with DNA hypomethylation agent + CAG regimen in patients with relapsed/refractory acute myeloid leukemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 8, p. 2769, doi. 10.1007/s00262-023-03454-y
- By:
- Publication type:
- Article